Molecular Signatures of HPV+ ORL Cancers (OROPAP)

Assistance Publique - Hôpitaux de Paris

Status: Completed

Conditions: Oropharyngeal Cancer; Human Papillomavirus-Related Carcinoma

Study type: Observational

Funder types: Other

Identifiers

NCT04189003

APHP180166 (Other Identifier)

Details and patient eligibility

About

The aim of this study is to identify HPV molecular signature in head and neck cancer to establish a new classification for positive human papillomavirus oropharyngeal tumor

Full description

OROPAP is a monocentric exploratory study with retrospective inclusion of patients.

The retrospective study focus on patients who have had surgery for HPV-positive oropharyngeal tumors whose survival is at least 2 year.

Frozen and or FFPE biopsies of these tumors and frozen blood samples are available via the HEGP biological resources platform.

The HPV molecular signatures will be identified by the capture-HPV technique.

For each patient, clinical-anatomo-pathological data such as tumor size, tumor stage, presence or absence of metastasis, histological stage, different treatment lines and 2-years survival data will be collected through the use of data warehouse available on the HEGP.

Enrollment: 66 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with HPV + oropharyngeal cancer

Exclusion criteria

• NA